PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb

Größe

£290.00

SKU:: BME100155P
Zusätzliche Namen:: BIIB 059; BIIB-059; BIIB059
Lagerbedingungen:: Store at 2[o]C-8[o]C for 6 months
Hersteller:: DIMA Biotechnology Ltd
Host:: Human
Reaktivitäten:: Human
Formulierung:: Liquid PBS with 0.05% Proclin300; 1% BSA
Target:: CLEC4C
Weitere Details:: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.